Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
What is the purpose of this trial?
RATIONALE: Gathering health information about patients with acute lymphoblastic leukemia may help doctors learn more about the disease and plan the best treatment.
PURPOSE: This research study is developing a risk-based classification system for patients with newly diagnosed acute lymphoblastic leukemia.
- Up to 30 Years
- Children's Oncology Group
National Cancer Institute (NCI)
- August 2010
- Last Updated:
- June 3, 2013
- Study HIC#:
Clinicaltrials.gov ID: NCT01142427